Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 44
Growth YoY: +20.1%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 651–700 of 1,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05642962	Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)	active not recruiting	Phase 1 / Phase 2	17	Memorial Sloan Kettering Cancer CenterOTHER	1	Feb 25, 2026	clinicaltrials
NCT07433283	Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor	recruiting	Phase 1 / Phase 2	54	Sichuan Enray Pharmaceutical Sciences CompanyOTHER	1	Feb 25, 2026	clinicaltrials